Advertisements
Advertisement

Buy Jubilant Life Sciences, target price Rs 515: Motilal Oswal

Buy Jubilant Life Sciences, target price Rs 515: Motilal Oswal.....»»

Category:finance~marketSource:  theeconomictimesJun 1st, 2020


Brokerages mixed on Tata Motors post Q1 numbers

Brokerages mixed on Tata Motors post Q1 numbers.....»»

Category: finance~marketSource:  theeconomictimesRelated NewsAug 3rd, 2020

Buy Gujarat State Petronet; target of Rs 300: Motilal Oswal

Buy Gujarat State Petronet; target of Rs 300: Motilal Oswal.....»»

Category: finance~latestSource:  moneycontrolRelated NewsJun 10th, 2020

Buy PI Industries; target of Rs 1835: Motilal Oswal

Buy PI Industries; target of Rs 1835: Motilal Oswal.....»»

Category: finance~latestSource:  moneycontrolRelated NewsJun 10th, 2020

Stock Ideas: Motilal Oswal has a buy on Hindalco, target price Rs 175

Stock Ideas: Motilal Oswal has a buy on Hindalco, target price Rs 175.....»»

Category: finance~marketSource:  theeconomictimesRelated NewsMay 22nd, 2020

Buy HCL Technologies; target of Rs 615: Motilal Oswal

Buy HCL Technologies; target of Rs 615: Motilal Oswal.....»»

Category: finance~latestSource:  moneycontrolRelated NewsMay 21st, 2020

Buy ICICI Securities, target price Rs 460: Motilal Oswal

Buy ICICI Securities, target price Rs 460: Motilal Oswal.....»»

Category: finance~marketSource:  theeconomictimesRelated NewsMay 21st, 2020

Trending stocks: Jubilant Life Sciences share price climbs 5%

Trending stocks: Jubilant Life Sciences share price climbs 5%.....»»

Category: finance~marketSource:  theeconomictimesRelated NewsMay 13th, 2020

Jubilant Life Sciences share price hits upper circuit on pact with Gilead to make remdesivir

Jubilant Life Sciences share price hits upper circuit on pact with Gilead to make remdesivir.....»»

Category: finance~latestSource:  businesstodayRelated NewsMay 13th, 2020

Coronavirus: Gilead seeks marketing authorisation from India for remdesivir

Coronavirus: Gilead seeks marketing authorisation from India for remdesivir.....»»

Category: finance~bizwrapSource:  businesstodayRelated NewsMay 30th, 2020

Jubilant Life Sciences Q4 results: Posts Rs 260.49 crore profit

Jubilant Life Sciences Q4 results: Posts Rs 260.49 crore profit.....»»

Category: finance~marketSource:  theeconomictimesRelated NewsMay 29th, 2020

Market Ahead, May 29: All you need to know before the opening bell

Market Ahead, May 29: All you need to know before the opening bell.....»»

Category: finance~todays-paperSource:  businessstandardRelated NewsMay 29th, 2020

Stocks in news: Metropolis, Everest Industries, Jubilant Life Sciences, TVS Motors, Heidelberg, CEAT and more

Stocks in news: Metropolis, Everest Industries, Jubilant Life Sciences, TVS Motors, Heidelberg, CEAT and more.....»»

Category: finance~latestSource:  businesstodayRelated NewsMay 29th, 2020

Hold Jubilant Foodworks, target price Rs 1,500: ICICI Securities

Hold Jubilant Foodworks, target price Rs 1,500: ICICI Securities.....»»

Category: finance~marketSource:  theeconomictimesRelated NewsMay 21st, 2020

The week gone by in 10 stocks: BHEL, Vedanta, SpiceJet, Jubilant Life Sciences

The week gone by in 10 stocks: BHEL, Vedanta, SpiceJet, Jubilant Life Sciences.....»»

Category: finance~marketSource:  theeconomictimesRelated NewsMay 17th, 2020

Jubilant Life, Cipla rally up to 6% on inking pact with Gilead Sciences

Jubilant Life, Cipla rally up to 6% on inking pact with Gilead Sciences.....»»

Category: finance~companySource:  businessstandardRelated NewsMay 13th, 2020

Jubilant Life Sciences enters into licensing agreement with Gilead for Remdesivir

Jubilant Life Sciences enters into licensing agreement with Gilead for Remdesivir.....»»

Category: finance~stockSource:  indiainfolineRelated NewsMay 13th, 2020

Jubilant Life enters into licensing pact with Gilead for Remdesivir

Jubilant Life enters into licensing pact with Gilead for Remdesivir.....»»

Category: finance~latestSource:  businesslineRelated NewsMay 13th, 2020

India"s Jubilant Signs Licensing Deal For US Pharma Firm"s COVID-19 Drug

India"s Jubilant Signs Licensing Deal For US Pharma Firm"s COVID-19 Drug.....»»

Category: news~latestSource:  ndtvRelated NewsMay 13th, 2020

Jubilant Life Sciences first to produce Gilead"s coronavirus drug Remdesivir in India

Jubilant Life Sciences first to produce Gilead"s coronavirus drug Remdesivir in India.....»»

Category: finance~latestSource:  businesstodayRelated NewsMay 12th, 2020

Buy SBI Life Insurance Company, target price Rs 792: Dharmesh Shah

Buy SBI Life Insurance Company, target price Rs 792: Dharmesh Shah.....»»

Category: finance~marketSource:  theeconomictimesRelated NewsMay 12th, 2020